Radiopharm Theranostics Ltd (RADX) Other Accumulated Expenses (2024 - 2025)

Radiopharm Theranostics (RADX) has reported Other Accumulated Expenses for 2 consecutive years, with $155583.6 the latest figure, recorded in Q2 2025.

• In Q2 2025, Other Accumulated Expenses fell 4.92% year-over-year to $155583.6; the TTM figure through Jun 2025 stood at $155583.6 (down 4.92% YoY), while the FY2025 annual figure was $155583.6, down 4.92% from the prior year.
• Other Accumulated Expenses slipped to $155583.6 in Q2 2025 per RADX's latest filing, from $163637.1 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $163637.1 in Q2 2024 and bottomed at $155583.6 in Q2 2025.